The Patent Finder

Dexcel Pharma Technologies Ltd.

18 patents currently held · Updated Nov 17, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

1
Ending by 2030
Jan 2030
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jul 21, 2027
    The maintenance fee for Compositions comprising dexamethasone (US 10,537,585) comes due Jul 21, 2027. Unpaid by Jan 21, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 12,599,565Stable Benzimidazole Formulation
In force
 · Medium confidence
In forceMedium confidence
US 8,865,198Method for treating a periodontal disease
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,889,090Method for treating a periodontal disease
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,757,338Sustained-release donepezil formulation
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,172,882Pharmaceutical compositions comprising ferric citrate and methods for the production thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,299,583Alternating and semi-alternating poly(ester-anhydride) copolymers
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,077,055Orally disintegrating compositions
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,076,494Stable orally disintegrating pharmaceutical compositions
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,835,488Stable orally disintegrating pharmaceutical compositions
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,774,176Alternating and semi-alternating poly(ester-anhydride) copolymers
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 18 patents shown.
Pro members see all 18.
Pro members: see all 18 patents
Also on record, not counted in the 18: 6 lapsed for an unpaid fee · 6 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending · 1 abandoned · 16 no status recorded

Showing 1 to 10 of 18, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
19/299,711Methods for Treating Allan-Herndon-Dudley SyndromeAug 14, 2025Pending
17/570,548Jan 7, 2022No status recorded
16/239,922Jan 4, 2019No status recorded
15/801,886Nov 2, 2017No status recorded
15/724,502Oct 4, 2017No status recorded
16/326,954Ophthalmic CompositionsSep 3, 2017Abandoned
15/118,594Apr 21, 2016No status recorded
14/168,911Jan 30, 2014No status recorded
14/053,611Oct 15, 2013No status recorded
13/196,545Aug 2, 2011No status recorded
10 of 18 applications shown.
Pro members see all 18 published applications.
Pro members: see all 18 applications
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited